Navigation Links
Demand for Product Pipeline Review and Analysis Rises in the Global Pharma Industry
Date:6/28/2012

NEW YORK, LONDON, BERLIN, PARIS, June 28, 2012 /PRNewswire/ --

Pharma Product Pipeline Review and Competitor analysis reports have seen a steady rise in the Pharma and Healthcare Industry lately. The product pipeline reports are segregated into company based pipeline review and disease based pipeline reports.

The company based pipeline review talks about a particular company's research and development focus, information on current developmental pipeline and features on discontinued and dormant projects for all disease and conditions. Whereas the disease based pipeline reports provide information on the therapeutic development, special features on the clinical stage, late-stage and discontinued projects for that particular disease.

Scope of the Company based pipeline review and analysis

  • Overview of the company including business description, key information and facts and its locations and subsidiaries.
  • Review of current pipeline of the company's human therapeutic division.
  • Overview of pipeline therapeutics across various therapy areas.
  • Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
  • Product profiles for clinical stage products and late stage products with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
  • Key discontinued and dormant projects.
  • Latest news and deals relating to the products of the company.

Scope of the Disease based pipeline review and analysis:

  • Provides snapshot of the global therapeutic scenario for the disease.
  • Presents review of the products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
  • Coverage of products based on various stages of development ranging from discovery till registration stages.
  • Detailed feature on pipeline projects on the basis of monotherapy and combined therapeutics.
  • Coverage of the disease pipeline on the basis of route of administration and molecule type.
  • Profiles of late-stage pipeline products featuring sections on product description, mechanism of action and research & development progress.
  • Key discontinued pipeline projects along with the latest news and deals relating to the product.

Some of the Company Product Pipeline Analysis Reports -

Celldex Therapeutics Product Pipeline Review 2012

Dr. Reddy's Laboratories Product Pipeline Review 2012

Galderma Product Pipeline Review 2012

Gilead Sciences Product Pipeline Review 2012

Hospira Product Pipeline Review 2012

bioMerieux Product Pipeline Analysis

Some of the Disease Pipeline Analysis Reports :

Emphysema - Pipeline Review, H1 2012

Pheochromocytoma - Pipeline Review, H1 2012

Obsessive-Compulsive Disorder Pipeline Review, H1 2012

Auto Inflammatory Disease - Pipeline Review, H1 2012

Thyroid Gland Disorders  Pipeline Review, H1 2012

About Reportstack™ :

Reportstack.com is one of the leading distributors of market research reports in the world today. Reportstack hosts more than 150,000 research products from the world's top publication houses. These publications are distributed amongst 12 top industry verticals and 62 sub verticals, which are then further classified into 257 business categories and 5000 micro markets. The vast selection criterion provides granular data from the length and breadth of all these industries delivering Reportstack.com members with cutting edge research products to facilitate strategic business decisions. Reportstack.com gives you access to over 50,000 company profiles and their strategic information like SWOT analysis reports, deals and partnerships analysis, merger & acquisition activity and new product launches. Reportstack.com is also a leader in the field of Pharma Disease Partnering research and Disease Competitor Analysis.

Contact Reportstack.com:
Nathan Gold
Phone: +1 888-789-6604
Email: Info@reportstack.com
Twitter : http://twitter.com/#!/reportstack
Facebook : http://www.facebook.com/pages/Reportstack/182382778485635    
Linkedin :  http://www.linkedin.com/company/reportstack
Blogs: Pharma Research Reports
Pharmaceutical Market Research Reports



'/>"/>
SOURCE Reportstack.com
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Diabetes Care Devices in Emerging Countries (China, India, Brazil) to 2017 - Greater Awareness is Increasing Demand for Self-Monitoring of Blood Glucose (SMBG) in the Home Care Segment
2. Konica Minolta Sensing America Launches Spanish Website in Support of Growing Demand In Latin American Countries
3. Masimo Deploys Kinaxis RapidResponse for Global Demand and Supply Balancing
4. Wound Management Products Market Reaches $15.2 Billion by 2016, Driven by Rising Demand for Bandages and Dressings in Developing World
5. Global Market for Medical Imaging Equipment to Reach $25.3 Billion as Retiring Boomers and Emerging Markets Demand Better Healthcare
6. Galena Biopharma, Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
7. ChromaDex® Experiencing Higher Than Expected Demand For Its Recently Launched BluScience™ Line of Dietary Supplements
8. Provectus Pharmaceuticals, Inc.s Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
9. Nature Made Selected As "Top Recommended Health Product" By U.S. News & World Report And Pharmacy Times
10. Albemarle expands South Haven API production site
11. PrimeraDx Announces Commencement of Product Development Collaboration with Eli Lilly and Company
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... DUBLIN , June 27, 2016 Jazz ... the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act ... proposed acquisition of Celator Pharmaceuticals, Inc. ("Celator"; Nasdaq: ... 11:59 p.m. (Eastern Daylight Time). As previously ... entered into a definitive merger agreement under which Jazz ...
(Date:6/24/2016)... June 24, 2016  Global Blood Therapeutics, Inc. (GBT) ... developing novel therapeutics for the treatment of grievous ... the closing of its previously announced underwritten public ... the public offering price of $18.75 per share. ... offered by GBT. GBT estimates net proceeds from ...
(Date:6/24/2016)... , June 24, 2016 Dehaier Medical Systems ... "Company"), which develops, markets and sells medical devices and ... , signed a strategic cooperation agreement with Hongyuan Supply ... Supply Chain") on June 20, 2016, to develop Dehaier,s ... strategic cooperation agreement, Dehaier will leverage Hongyuan Supply Chain,s ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... 27, 2016 , ... Quality metrics are proliferating in cancer care, and are ... the eye of the beholder, according to experts who offered insights and commentary in ... Managed Care. For the full issue, click here . , For the American ...
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... ... fertility once they have been diagnosed with endometriosis. These women need a treatment ... also require a comprehensive approach that can help for preservation of fertility and ...
(Date:6/25/2016)... Lewisville, TX (PRWEB) , ... June 25, 2016 , ... ... in the United States, named Dr. Sesan Ogunleye, as the Medical Director of its ... be the facility Medical Director of our new Mesquite location,” said Dr. James M. ...
(Date:6/24/2016)... , ... June 24, 2016 , ... A recent ... most people are unfamiliar with. The article goes on to state that individuals are ... many of these less common operations such as calf and cheek reduction. The Los ...
(Date:6/24/2016)... Fla. (PRWEB) , ... June 24, 2016 , ... Global ... Trend magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this recognition ... Florida. , Seven Greenberg Traurig Shareholders received special honors as members of this year’s ...
Breaking Medicine News(10 mins):